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Received 25 August 2010; received in revised form 25 October 2010; accepted 2 December 2010AbstractThe growing demand of medicinal plants is posing a major threat to biodiversity conservation. Sclerocarya birrea and Harpephyllum caffrum
(Anacardiaceae) are traditionally used to treat numerous ailments increasing their susceptibility to overexploitation. The aim of the study was to
evaluate the medicinal efficacy of renewable aerial parts of the plants using in vitro assays, thus providing a conservation measure by plant part
substitution. Plant samples were sequentially extracted with petroleum ether, dichloromethane and 80% ethanol, sonicated on ice and concentrated
under vacuum. Antimicrobial activities were determined by the minimum inhibition concentration (MIC) using the micro-dilution assay. The
ability of extracts to inhibit COX-1 and COX-2 enzymes was used to evaluate anti-inflammatory activity. Ethanolic extracts of S. birrea and
H. caffrum exhibited high antibacterial activity (MIC b1.0 mg/ml). S. birrea twig extract was the most active with a total activity of 1609.1 ml/g
against Bacillus subtilis and an MIC of 0.098 mg/ml. Petroleum ether and dichloromethane extracts exhibited high COX-1 (90.7–99.8%) and
COX-2 (69–92.6%) enzyme inhibition at a concentration of 250 μg/ml. The extracts of S. birrea and H. caffrum exhibited high antimicrobial and
anti-inflammatory properties. Based on these results, plant part substitution can be a practical conservation strategy for the two species.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.
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In most parts of Africa, including South Africa, the utilisation
of plants for medicinal purposes is a well established practice. The
growing demand for medicinal plants, possibly arising from the
high levels of poverty and rising costs of modern medicine,
continues to exert sustained pressure on the limited plant resource
base, posing a major threat to biodiversity conservation. A major
concern emanating from this growing demand for medicinal
plants is the decimation of tree species, which have long
regeneration cycles, through the harvesting of mature bark and
roots. The over-exploitation of medicinal plants from their natural
habitats has long been a global challenge (Jäger and Van Staden,
2005). In KwaZulu-Natal, South Africa, bark from primary tree⁎ Corresponding author. Tel.: +27 33 2605130; fax: +27 33 2605897.
E-mail address: rcpgd@ukzn.ac.za (J. Van Staden).
0254-6299/$ - see front matter © 2010 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2010.12.001trunks and roots frommature trees accounted for a combined total
of 54% (27% each) of the medicinal market products sold by
traders (Mander, 1998). Other studies in South Africa have also
reported high utilisation of trees for medicinal purposes (32%)
and a corresponding high preference (83%) for mature bark by
traders (Zschocke et al., 2000a). A number of conservation
options have been proposed to curtail the destructive utilisation of
medicinal plants, for example, establishment of conservation
areas, law enforcement against bark collections, large-scale
cultivation of popular species (Zschocke et al., 2000a), plant
and plant part substitution (Jäger and Van Staden, 2005).
However, most of these conservation strategies are long-term
and have to be implemented inclusivelywith short-term options to
cater for a sustained supply of medicinal remedies. Plant
substitution, though practical, may be resisted by consumers
who may not readily accept alternative plants (Zschocke et al.,
2000a). Instead, a practical alternative strategy could be plant partts reserved.
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twigs and leaves which could lead to non-destructive harvesting
(Jäger and Van Staden, 2005). Thus, as part of an overall
conservation strategy, medicinal plant research should include
investigations into parts that are less traditionally used such as
twigs and leaves (Zschocke et al., 2000a).
Anacardiaceae tree species are commonly used as bio-
resources formedicinal remedies. For example, Spondiasmombin
has been reported to be an important component of traditional
health care in the West Indies, southern Mexico, Peru, Brazil,
Equatorial Guinea, Cote D'lvoire, Nigeria and Sierra Leone
(Ayoka et al., 2006). Lima et al. (2006) reported on the medicinal
uses of the bark, leaves, roots and flowers ofMangifera indica in
the treatment of diarrhoea, fever, gastritis and ulcers. In South
Africa, Sclerocarya birrea (A. Rich.) Hochst. subsp. caffra
(Sond.) Kokwaro and Harpephyllum caffrum Bernh. ex Krauss,
are used extensively in folkmedicine for a wide range of ailments,
including diarrhoea, dysentery, malaria, fevers, headaches and
inflammations (Buwa and Van Staden, 2006; Eloff, 2001;
McGaw et al., 2000; Ojewole, 2003). The main part used in the
treatment of bacterial and inflammation conditions is the mature
bark of both S. birrea (McGaw et al., 2000) and H. caffrum
(Buwa and Van Staden, 2006). Mature bark of S. birrea and
H. caffrum was the preferred plant part sold by medicinal traders
for both species in KwaZulu-Natal (Mander, 1998). S. birrea and
H. caffrum accounted for approximately 7% and 5%, respective-
ly, ofmedicinal plants sold by traders inKwaZulu-Natal (Mander,
1998). Though the two species are not extinct, continued
unchecked harvesting of the bark for medicinal purposes poses
a major threat to their conservation. The purpose of this study was
to evaluate renewable plant parts (twigs and leaves) of S. birrea
and H. caffrum for antimicrobial bioactivity; and inhibition of
cyclooxygenase-1 and -2 enzymes, which are primarily involved
in the biosynthesis of prostaglandins in inflammation processes.
2. Materials and methods
2.1. Chemicals
Yeast malt (YM) broth, Mueller-Hinton (MH) broth, neomy-
cin, amphotericin B, adrenaline, glutathione (reduced form),
prostaglandin E2, indomethacin, cyclooxygenase-1 (COX-1,
isolated from ram seminal vesicles), cyclooxygenase-2 (COX-2,
human recombinant expressed in Sf 21 cells), arachidonic acid,
[14C] arachidonic acid and p-iodonitrotetrazolium chloride (INT)
were purchased from Sigma-Aldrich (Sigma Chemical Co.,
Steinheim, Germany). Silica gel 60 (particle size 0.063–0.200,
70–230 mesh ASTM), petroleum ether (PE), ethanol (EtOH),
dichloromethane (DCM) and dimethyl sulfoxide (DMSO) were
obtained from Merck KGaA (Darmstadt, Germany). All
chemicals used in the assays were of analytical grade.
2.2. Plant material
H. caffrum plant material was collected in December 2008
from the University of KwaZulu-Natal Botanical Gardens,
Pietermaritzburg, South Africa. Plant parts were separatedinto leaves and the bark was stripped off the twigs and oven
dried at 50 °C for three days. S. birrea plant material was
obtained from St. Lucia, KwaZulu-Natal, South Africa in
November 2008. Plant parts were separated into leaves and
twigs and oven dried at 50 °C for three days. Voucher
specimens, MOYO 1 and MOYO 2 for S. birrea and H.
caffrum, respectively, were identified and deposited in the Natal
University (NU) Herbarium at the University of KwaZulu-
Natal, Pietermaritzburg.
2.3. Preparation of plant samples
The dried samples were ground into fine powders using a
blender (IKA® All basic, Wilmington, USA), and extracted
sequentially with petroleum ether, dichloromethane and 80%
ethanol. Extractionswere done on ice in a sonication bath (Branson
model 5210, Branson Ultrasonics B.V., Soest, The Netherlands)
using 20 ml of extraction solvent per g of plant extract for 1 h. The
extracts were vacuum-filtered throughWhatmanNo. 1 filter paper,
concentrated under vacuum (Rotavapor-R, Büchi, Switzerland) at
30 °C and dried at room temperature under a stream of cold air
until a constant dry weight was obtained. The dried extracts were
stored in sample bottles at 10 °C in the dark.
2.4. Antibacterial microdilution assay
The minimum inhibition concentration (MIC) of the plant
extracts was determined using the serial micro-dilution assay
(Eloff, 1998) as outlined by Amoo et al. (2009). Four bacteria
consisting of twoGram-positive (Bacillus subtilisATCC6051 and
Staphylococcus aureus ATCC 12600) and two Gram-negative
(Escherichia coliATCC11775 andKlebsiella pneumoniaeATCC
13883) strains were tested. Overnight bacterial cultures were
diluted with sterileMueller-Hinton (MH) broth to a final inoculum
concentration of 106colony forming units (CFU)/ml. The plant
extracts were re-suspended in 80% ethanol to a concentration of
50 mg/ml. A positive control, neomycin (100 μl, 100 μg/ml in the
first well) was used against each bacterial strain. Distilled water
and 80% ethanol served as the negative and solvent controls
respectively. The minimum bacterial concentration (MBC) was
determined by adding MH broth (50 μl) to each of the clear wells
(no bacterial growth), followed by further incubation at 37 °C for
24 h (Kuete et al., 2008; Pavithra et al., 2009). The assaywas done
in duplicate and repeated twice.
2.5. Antifungal assay
The micro-dilution assay (Eloff, 1998) with modifications
(Masoko et al., 2007) was used in the determination of antifungal
activity against a standard strain of Candida albicans (ATCC
10231) as detailed by Ndhlala et al. (2009). An overnight culture
ofC. albicans inYeastMalt (YM) brothwas incubated at 37 °C in
a water bath on an orbital shaker and used to prepare final
inoculums of approximately 106CFU/ml. All plant extracts were
re-suspended in 80% ethanol to a concentration of 50 mg/ml. The
positive control, amphotericin B was prepared in DMSO and
diluted 10 times with sterile distilled water to a final concentration
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solvent controls respectively. The minimum fungicidal concen-
tration (MFC) was determined by adding YM broth (50 μl) to
each of the clear wells, followed by a further incubation at 37 °C
for 24 h. The assay was done in duplicate and repeated twice.
2.6. Anti-inflammatory activity using cyclooxygenase (COX-1,
COX-2) assays
Anti-inflammatory activities of the plant extracts were
evaluated on their ability to inhibit prostaglandin synthesis
using COX-1 and COX-2 enzyme assays (Jäger et al., 1996;
White andGlassman, 1974) and as outlined by Zschocke andVan
Staden (2000). Controls for both COX-1 and COX-2 assays
included a solvent blank, background and an indomethacin
standard. Inhibition of prostaglandin synthesis was calculated by
comparing the radioactivity of test reactions to that of the solvent
blank using the formula:
Inhibition %ð Þ = 1− DMPsample−DMPbackground
DMPsolvent blank−DMPbackground
  
× 100
where DMP(sample), DMP(background) and DMP(solvent
blank) represent the radioactivity counts of the plant extract,
background and solvent blank, respectively.
3. Results and discussion
3.1. Antibacterial activity
The results of the antibacterial assay (MIC and MBC) are
presented in Table 1. Extracts of S. birrea showed high bioactivityTable 1
In vitro antibacterial activity of S. birrea and H. caffrum crude extracts.
Plant part Solvent Yield
(mg/g of sample)
MIC (mg/ml)
B. s b S. a E. c
S. birrea
Leaf PE 30.4 3.125 3.125 3.125
DCM 9.0 3.125 3.125 6.250
EtOH 309.2 0.390 c 0.390 0.390
Twigs PE 2.7 0.390 0.390 1.560
DCM 14.6 0.390 0.780 3.125
EtOH 157.7 0.098 0.195 0.390
Opercula PE 1.8 0.390 0.390 1.560
DCM 1.5 1.560 0.780 3.125
EtOH 16.9 0.780 0.780 1.560
H. caffrum
Leaf PE 28.8 3.125 6.250 6.250
DCM 6.3 3.125 1.560 3.125
EtOH 148.0 0.780 0.390 1.560
Twig bark PE 30.0 3.125 3.125 6.250
DCM 3.6 3.125 1.560 3.125
EtOH 249.0 0.195 0.195 0.780
Neomycin (μg/ml) 0.195 0.780 6.250
a Total activity was calculated for each plant extract based on the bacterial strain
b B. s = Bacillus subtilis; S. a = Staphylococcus aureus; E. c = Escherichia coli;
c Extracts with values in bold font are considered very active (MIC b1.0 mg/ml).against Gram-positive bacteria (B. subtilis and S. aureus). For H.
caffrum, ethanolic extracts were most active (MIC b1.0 mg/ml)
against Gram-positive bacteriawhen compared to petroleum ether
and dichloromethane extracts. The highest activity against Gram-
positive bacteria (MIC≤0.195 mg/ml) was recorded for S. birrea
twig, and H. caffrum twig bark extracts. The highest activity
(MIC b1.0 mg/ml) against Gram-negative bacteria (E. coli and
K. pneumoniae) was achievedwith ethanolic fractions of S. birrea
twig, S. birrea leaf and H. caffrum twig bark extracts. Using
S. birrea mature bark ethanolic extracts, McGaw et al. (2000)
reported high antibacterial activity against the Gram-positive
strains of B. subtilis (0.012 mg/ml) and S. aureus (0.049 mg/ml).
Buwa andVan Staden (2006) reported high antibacterial activities
of H. caffrum ethanolic extracts against B. subtilis (0.098 m/ml),
S. aureus (0.195 mg/ml) and E. coli (0.78 mg/ml). The results of
previous studies using mature bark are comparable to the current
research findings using renewable plant parts such as twigs. In
both cases, Gram-positive bacteria were more sensitive to the
extracts than Gram-negative bacteria. In general, Gram-negative
bacteria are more resistant and impermeable to certain antibac-
terial compounds compared to Gram-positive bacteria due to the
complex and unique multilayered organization of the cell wall
containing lipopolysaccharides and a peptidoglycan-containing
matrix (Cos et al., 2006; Risco and Pinto da Silva, 1998). This
structural feature may explain the reported difference in
sensitivity to plant extracts between Gram-positive and Gram-
negative bacteria (Eldeen et al., 2005; Rabe and Van Staden,
1997). TheMIC values of the different extracts were translated to
total antibacterial activity by dividing the quantity extracted per g
by the MIC value (Eloff, 2001). Based on the most susceptible
bacterial strain, ethanolic extracts were the most active with total
activities in the order, S. birrea twig (1609.1)NH. cafrum twigTotal activity
(ml/g) a
MBC (mg/ml)
K. p B. s S. a E. c K. p
6.25 9.7 12.50 12.50 12.50 12.50
6.25 2.8 3.125 6.250 6.250 6.250
0.78 792.8 1.560 1.560 3.125 3.125
1.56 6.9 1.560 3.125 6.250 3.125
1.56 37.4 3.125 3.125 6.250 6.250
0.39 1609.1 1.560 1.560 3.125 6.250
1.56 4.6 6.250 3.125 3.125 3.125
1.56 1.9 3.125 3.125 3.125 6.250
1.56 21.6 1.560 1.560 6.250 6.250
6.250 9.2 N12.50 N12.50 N12.50 N12.50
3.125 4.0 12.50 12.50 6.250 12.50
1.560 379.4 3.125 1.560 6.250 3.125
6.250 9.6 12.50 12.50 12.50 12.50
3.125 2.3 3.125 6.250 6.250 6.250
0.780 1276.9 3.125 3.125 3.125 6.250
1.560 3.125 3.125 6.250 6.250
with the lowest MIC value.
K. p = Klebsiella pneumoniae.
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S. birrea opercula (21.6 ml/g) (Table 1). For example, the
bioactive compounds present in 1 g of S. birrea twig extracts
would still inhibit B. subtilis growth when diluted to 1609.1 ml.
The potency of S. birrea twigs was twice that of leaf extracts.
H. caffrum twig bark extract was 3.3 times more potent than the
leaf extract. Conversely, Eloff (2001) reported that the total
activity of S. birrea leaf extractswas 11 times less active than stem
bark extracts. The present results suggest that S. birrea leaves can
effectively be used for the treatment of bacterial ailments. In the
bactericidal evaluation, ethanolic fractions of S. birrea twig, leaf,
and opercula extracts were most active (MBC=1.56 mg/ml)
against Gram-positive bacteria.A
tio
n 
(%
)
40
60
80
100
62.5 µg/ml
125 µg/ml
250 µg/ml3.2. Antifungal activity
Antifungal activity of the plant extracts was evaluated using
C. albicans and the obtained MIC and MFC values are presented
in Table 2. The therapy of fungal infections caused by oppor-
tunistic pathogens such as C. albicans remains a major medical
challenge (Sangetha et al., 2009). Infection byC. albicans leads to
the formation of a biofilm which is resistant to the penetration of
antifungal agents (Sangetha et al., 2009). The most active extract
was S. birrea twig ethanolic fraction (MIC=1.56 mg/ml and
MFC=1.56 mg/ml). H. caffrum leaf and all S. birrea ethanolic
extracts recorded MIC and MFC values of 3.125 mg/ml against
C. albicans. The MIC value for H. caffrum twig bark extracts
(3.125 mg/ml) is still comparable to that reported by Buwa and
Van Staden (2007) for mature bark extracts (1.56 mg/ml). Based
on total activity, ethanolic fractions had the highest potency
against C. albicans in the order, S. birrea twig (101.0)NS. birrea
leaf (98.9)NH. caffrum twig bark (79.6)NH. caffrum leaf
(47.3 mg/ml). The results indicate that S. birrea leaves are as
effective as twig extracts. Almost twice the dose ofH. caffrum leafTable 2
In vitro antifungal activity against C. albicans of S. birrea and H. caffrum crude
extracts.
Plant species Plant
part
Solvent MIC
(mg/ml)
MFC
(mg/ml)
Yield
(mg/g)
Total
activity
(ml/g)
S. birrea Leaf PE 6.250 6.250 30.4 4.8
DCM 3.125 3.125 9.0 2.8
EtOH 3.125 3.125 309.2 98.9
Twigs PE 6.250 6.250 2.7 0.4
DCM 3.125 6.250 14.6 4.6
EtOH 1.560 1.560 157.7 101.0
Opercula PE 6.250 6.250 1.8 0.2
DCM 3.125 6.250 1.5 0.4
EtOH 3.125 3.125 16.9 5.4
H. caffrum Leaf PE 3.125 4.688 28.8 9.2
DCM 3.125 6.250 6.3 2.0
EtOH 3.125 3.125 148.0 47.3
Twig bark PE 3.125 4.688 30 9.6
DCM 4.688 6.250 3.6 0.7
EtOH 3.125 4.688 249.0 79.6
Amphotericin
B (μg/ml)
4.82×10−2 1.93×10−1extract is required for an equal effect as exhibited by H. caffrum
twig bark extract against C. albicans. Buwa and Van Staden
(2006) obtained comparable antimicrobial MIC results for
ethanolic H. caffrum mature bark extracts. Using an ultrastruc-
tural approach, Sangetha et al. (2009) showed that Cassia
spectabilis leaf extract prevented formation ofC. albicans biofilm
at an MIC of 6.25 mg/ml. Findings of the present study suggest
that S. birrea and H. caffrum extracts may also function by
interfering with formation of a C. albicans biofilm.
3.3. Cyclooxygenase enzyme assays for anti-inflammatory
activity
The bioactivity of plant extracts in the inflammation process
was evaluated on their ability to inhibit COX-1 and COX-2
enzymeswhich are involved in the biosynthesis of prostaglandins.
Results on percentage inhibition of COX-1 and COX-2 enzymes
by plant extracts at 250 μg/ml in the assay are presented in Figs. 1
and 2. For all extracts petroleum ether and dichloromethane
fractions showed high COX-1 enzyme inhibition (90.7–99.8%).
Petroleum ether and dichloromethane fractions exhibited high
inhibition against COX-2 enzyme (69.0–92.6%). Due to the high
activity of the extracts in the COX-2 assay, they were evaluated at
lower doses (125 and 62.5 μg/ml) against both cyclooxygenaseB
Plant extracts
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Fig. 1. Dose-dependent prostaglandin synthesis inhibitory activity (%) ofH. caffrum
and S. birrea (Anacardiaceae) plant extracts onCOX-1 enzyme. (A) Petroleum ether
extracts and (B) dichloromethane extracts. H.c. B, H. caffrum twig bark; H.c. L,
H. caffrum leaf; S.b. B, S. birrea twigs; S. birrea leaf; S.b. O, S. birrea opercula.
Percentage inhibition by indomethacin was 67.1±2.74%.
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Fig. 2. Dose-dependent prostaglandin synthesis inhibitory activity (%) ofH. caffrum
and S. birrea (Anacardiaceae) plant extracts onCOX-2 enzyme. (A) Petroleum ether
extracts and (B) dichloromethane extracts. H.c. B, H. caffrum twig bark; H.c. L,
H. caffrum leaf; S.b. B, S. birrea twigs; S. birrea leaf; S.b. O, S. birrea opercula.
Percentage inhibition by indomethacin was 67.1±2.62%.
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synthesis inhibition (%) when evaluated against the COX-1
enzyme. A similar relationship is presented in Fig. 2 for the COX-
2 enzyme. Both Figs. 1 and 2 show an increase in prostaglandin
synthesis inhibition with increasing concentrations of the plant
extracts. S. birrea is traditionally used in the treatment of several
ailments including snake and scorpion bites, and inflammations
(Braca et al., 2003). Using an animal experimental model,
Ojewole (2003) reported that S. birrea bark extracts possess anti-
inflammatory activity. Likewise, H. caffrum is reportedly used in
the alleviation of pain among other conditions (Buwa and Van
Staden, 2007; Jäger et al., 1996). The results of the anti-
inflammatory assay have shown that non-polar compounds of the
two species, extracted using PE and DCM, are more active
compared to ethanolic polar constituents in the prostaglandin
biosynthesis pathway against COX-1 and COX-2 enzymes
(results not shown). The high activity of the non-polar extracts
is likely due to lipophilic compounds, which are active in low
concentrations (Zschocke and Van Staden, 2000). Specific
cyclooxygenase inhibitors acting on their own or in synergism
with other active compounds in the extracts are responsible for the
anti-inflammatory activity (Zschocke et al., 2000b). The inactivity
of the polar extract against COX-2 enzyme suggests some specific
interference in the biosynthesis pathway. Zschocke et al. (2000b)showed that phenolic compounds extracted by polar solvents
interfere in enzyme bioassays through unspecific binding
phenomena. Furthermore, negative results do not necessarily
mean that the extracts are without anti-inflammatory activity, as
the active compound(s) could work at alternative sites in the
complex inflammation process (Jäger et al., 1996).
4. Conclusions
Plant part substitution as suggested by Zschocke et al.
(2000b) and Jäger and Van Staden (2005) can be a practical
conservation strategy for medicinal plants. Based on the
demonstrated high microbial and anti-inflammatory bioactiv-
ities of renewable aerial parts of both S. birrea and H. caffrum,
non-destructive harvesting of these species can be achieved.
Though the species are at present neither extinct nor threatened,
their multipurpose uses in traditional medicine makes them
highly vulnerable to over-exploitation, hence the need to protect
the available wild populations.
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